Polyphosphate binds with high affinity to exosite II of thrombin.
BACKGROUND
Polyphosphate (a linear polymer of inorganic phosphate) is secreted from platelet dense granules, and we recently showed that it accelerates factor V activation by thrombin.


OBJECTIVE
To examine the interaction of polyphosphate with thrombin.


RESULTS
Thrombin, but not prothrombin, altered the electrophoretic migration of polyphosphate in gel mobility assays. Thrombin binding to polyphosphate was influenced by ionic strength, and was evident even in plasma. Two positively charged exosites on thrombin mediate its interactions with other proteins and accessory molecules: exosite I (mainly with thrombin substrates), and exosite II (mainly with certain anionic polymers). Free thrombin, thrombin in complex with hirudin's C-terminal dodecapeptide and gamma-thrombin all bound polyphosphate similarly, excluding exosite I involvement. Mutations within exosite II, but not within exosite I, the Na(+)-binding site or hydrophobic pocket, weakened thrombin binding to polyphosphate as revealed by NaCl dependence. Surface plasmon resonance demonstrated tight interaction of polyphosphate with thrombin (K(d) approximately 5 nm) but reduced interaction with a thrombin exosite II mutant. Certain glycosaminoglycans, including heparin, only partially competed with polyphosphate for binding to thrombin, and polyphosphate did not reduce heparin-catalyzed inactivation of thrombin by antithrombin.


CONCLUSIONS
Polyphosphate interacts with thrombin's exosite II at a site that partially overlaps with, but is not identical to, the heparin-binding site. Polyphosphate interactions with thrombin may be physiologically relevant, as the polyphosphate concentrations achievable following platelet activation are far above the approximately 5 nM K(d) for the polyphosphate-thrombin interaction.
Mutch
N J
NJ
Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Myles
T
T
Leung
L L K
LL
Morrissey
J H
JH
D000991:Antithrombins / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive; D024202:Electrophoretic Mobility Shift Assay; D006493:Heparin / Q000378:metabolism; D006629:Hirudins / Q000378:metabolism; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D007700:Kinetics; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000378:metabolism; D011122:Polyphosphates / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D011516:Prothrombin / Q000378:metabolism; D012965:Sodium Chloride / Q000378:metabolism; D020349:Surface Plasmon Resonance; D013917:Thrombin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011122:Polyphosphates; C062510:hirugen; D012965:Sodium Chloride; D011516:Prothrombin; D006493:Heparin; D013917:Thrombin